To test the effects of RNAi-mediated FAS silencing on glioma cell growth, SNB-19 cells were transiently transfected with a range of concentrations of plasmid DNA of scrambled shRNA and FAS shRNA for 72 h. The gene discussed is FAS; the disease is central nervous system cancer.